Seguir
Vivienne C. Bachelet
Vivienne C. Bachelet
Associate professor, Chair of Evidence-based Medicine, School of Medicine, University of Santiago of
Dirección de correo verificada de usach.cl - Página principal
Título
Citado por
Citado por
Año
Do we know the diagnostic properties of the tests used in COVID-19? A rapid review of recently published literature
VC Bachelet
Medwave 20 (3), e7890, 2020
39*2020
A systematic review of the effectiveness of interventions to reduce motor vehicle crashes and their injuries among the general and working populations
Á Lefio, VC Bachelet, R Jiménez-Paneque, P Gomolán, K Rivas
Revista panamericana de salud publica 42, e60, 2018
372018
Violence and burnout in health care emergency workers in Santiago, Chile: A survey-based cross-sectional study
RE Jiménez, VC Bachelet, P Gomolán, LÁ Lefio, M Goyenechea
International emergency nursing 47, 100792, 2019
232019
Sex and gender analysis for better science and health equity
S Heidari, VC Bachelet
The Lancet 392 (10157), 1500-1502, 2018
222018
Policy strategies to reduce waiting times for elective surgery: a scoping review and evidence synthesis
VC Bachelet, M Goyenechea, VA Carrasco
The International journal of health planning and management 34 (2), e995-e1015, 2019
192019
Quality of reporting and risk of bias of randomized clinical trials published in Spanish and Latin American journals
VC Bachelet, H Pardo-Hernandez
Medwave 19 (1), e7573, 2019
15*2019
¿ Conocemos las propiedades diagnósticas de las pruebas usadas en COVID-19? Una revisión rápida de la literatura recientemente publicada. Rev Medwave. 2020[citado 29/05/2020 …
VC Bachelet
122020
Why the Helsinki Declaration now encourages trial registration, and publication and dissemination of the results of research
VC Bachelet, G Rada
Medwave 13 (10), e5846, 2013
12*2013
Missing clinical trial data, but also missing publicly-funded health studies
VC Bachelet
Medwave 13 (06), e5740, 2013
112013
A tale of harm, waste and deception: how big pharma has undermined public faith in trial data disclosure and what we can do about it
VC Bachelet
Medwave 13 (4), e5671, 2013
112013
Hospital concessions in Chile: where we are and where we are heading
VC Bachelet
Medwave 14 (10), 1-7, 2014
10*2014
Author misrepresentation of institutional affiliations: protocol for an exploratory case study
VC Bachelet, FA Uribe, RA Díaz, AF Vergara, F Bravo-Córdova, ...
BMJ open 9 (2), e023983, 2019
92019
Work-related injuries resulting in death in Chile: a cross-sectional study on 2014 and 2015 registries
VC Bachelet
BMJ open 8 (6), e020393, 2018
92018
The Tamiflu saga continues: will our conduct change after the publication of the latest systematic review on benefits and harms of oseltamivir
VC Bachelet
Medwave 14 (4), e5953, 2014
92014
Advancing women in science, medicine and global health: on the# LancetWomen special issue
VC Bachelet
Medwave 19 (2), e7598, 2019
72019
Inequality in health–OECD statistics for Chile
VC Bachelet
Medwave 11 (09), e5128, 2011
72011
Smoking and obesity in Chile's Third National Health Survey: light and shade
VC Bachelet, F Lanas
Revista Panamericana de Salud Pública 42, e132, 2018
62018
The biomedical publishing gap between the first world and the emerging world–Can it be overcome
VC Bachelet
Medwave 11 (07), 2011
6*2011
COST-EFFECTIVENESS EVALUATION OF SOCIAL VALUE OF AN INTERVENTION PROGRAM IN A VULNERABLE CHILD POPULATION, LAG OR DEFICIT IN INTEGRAL DEVELOPMENT-CHILE 2012
C Vallejos, R Reveco, VC Bachelet, M Goyenechea, M Velasquez, ...
Value In Health 16 (7), A710-A710, 2013
5*2013
Medwave adopts continuous publication
VC Bachelet, F Cardemil
Medwave 13 (3), e5649, 2013
52013
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20